Long- and Short-Acting Reversible Contraception, Including Current and New Options: Expanding Access and Choice

Long- and Short-Acting Reversible Contraception, Including Current and New Options: Expanding Access and Choice

Faculty Presenter

Ashley Meredith, PharmD, MPH
Clinical Associate Professor
Department of Pharmacy Practice
College of Pharmacy
Purdue University
West Lafayette, Indiana
 
Program Description

In the United States, approximately 45% of the 6 million pregnancies each year are unintended. Unintended pregnancies can pose a significant threat to public health, and nearly 95% are caused by incorrect, inconsistent, or lack of use of contraception. There are many different types of contraception available to women today, including hormonal and nonhormonal as well as short-acting and long-acting formulations. However, these methods can be ineffective if women are not educated regarding their proper use. Pharmacists need to be aware of the current barriers that women face when seeking appropriate contraception options. New legislation also allows some pharmacists to increase access to contraception by prescribing select products to their female patients. Due to the wide variety of contraceptive methods available, including recently approved ones, it is imperative that pharmacists understand the intricacies of options that women have and promote individualized care.

Target audience: Retail pharmacists
Type of activity: Application
Release date: April 15, 2021
Expiration date: April 15, 2022
Time to complete activity: 2 hours
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:
• Examine data surrounding unintended pregnancies and challenges associated with contraception for women
• Analyze current long-acting reversible contraception (LARC) and short-acting reversible contraception (SARC) options with an emphasis on the newest available formulations
• Differentiate the benefits, efficacy, and safety of LARC versus SARC methods
• Illustrate the pharmacist’s role in addressing patient challenges and providing recommendations for an optimal contraception option


 Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-21-151-H01-P. The activity is available for CE credit through April 15, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Ashley Meredith, PharmD, MPH, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Indiana Clinical Translational Science Institute
Consultant: Birth Control Pharmacist
Speakers Bureau: American College of Clinical Pharmacy, Surgent/Pharmcon LLC

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Kelly McCormick; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms